# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-014688
Filing Date
2023-04-28
Accepted
2023-04-28 16:05:23
Documents
3
Period of Report
2023-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 880760
2 |  | proxy_001.jpg | GRAPHIC | 357104
3 |  | proxy_002.jpg | GRAPHIC | 246792
| Complete submission text file | 0001493152-23-014688.txt |  | 1713523

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15911 | Film No.: 23865874
SIC: 2834 Pharmaceutical Preparations